-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on HCA Healthcare, Lowers Price Target to $485

Benzinga·07/27/2026 13:20:05
Listen to the news
Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $520 to $485.